Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Reassessing your budget at the right times keeps your finances aligned with life changes. Learn indicators that signal it’s time to review.
17,982 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
As Innventure gears up for its 2025 earnings report, investors seek clarity on growth, burn rate, and cash runway. Th...
Kohl's stunned investors with a strong swing in its latest quarterly results, sending the stock higher by double digi...
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
When high-growth fintech names stumble, markets react quickly. This piece breaks down Klarna’s Q4 miss, the stock mov...
AMD stock soared in May as AI-driven demand, data center expansion, and a refreshed product lineup converged to lift ...
Is Pfizer stock undervalued in the crowded healthcare space? This deep dive weighs cash flow, dividends, pipeline pot...
Bristol Myers Squibb stock often appears attractively priced, with a solid dividend. But when you look under the hood...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...
Telehealth is changing how we get care—and how we invest. This article breaks down the growth story, uses Hims & Hers...
Oklo has faced a challenging six months as the stock trended lower with little revenue to show. This article explores...